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Entrapment neuropathies
Abstract
Entrapment neuropathies are common in patients with advanced diseases including cancer. They may cause 
severe pain that is resistant to the treatment with known analgesics. This article reviews the syndromes of 
entrapment neuropathies relevant to palliative care. It also proposes simple treatment and aftercare. Be-
ing able to diagnose entrapment neuropathies and to treat them effectively, potentially, may decrease the 
doses of opioids needed to treat the pain.
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Introduction
Entrapment neuropathies (EN) are characterized 
by spontaneous and/or paroxysmal pain felt in the 
cutaneous or deep distribution of an involved sensory 
or mixed nerve, or corresponding to the anatomical 
course of the nerve trunk or its branches [1]. Pain 
is spread into the distribution of other nerves for 
the same limb and even to that of corresponding 
nerves on the opposite side [2]. The pain is more 
severe on movement and at those points where 
nerves can become trapped passing through narrow 
fibro-osseous tunnels or around bony prominences. 
Clinically, these areas can be seen as trigger points or 
“tic douloureux”. Spontaneous symptoms are de-
scribed as unusual tactile and thermal feelings as-
sociated with numbness, tingling, pins and needles, 
burning, shooting, and electric shock-like sensations.
The paroxysmal pain caused by EN may be re-
sponsible for many so-called “breakthrough” 
pains encountered in patients with advanced can-
cer, and needing specific diagnosis and treatment. 
Neuropathies affecting only motor nerves may cause 
painful cramps which are often seen in motor neu-
rone disease.
ENs are only rarely discussed in textbooks on 
cancer pain, perhaps because they are only occa-
sionally caused by tumour growth directly. More 
often they result from loss of elasticity of the sub-
cutaneous tissues, muscle weakness and increased 
mobility of the joints and bones and are due to 
the overuse of wasted muscles. This may happen 
when patients with advanced cancer decide to stay 
at home as long as possible and need to propel 
a wheelchair or walk on crutches. In general, because 
patients with cancer tend to live longer, they also 
tend to develop all kinds of pain related to debility, 
including pain due to EN. Nothing specific is known 
about the epidemiology of ENs, as this phenomenon 
is largely ignored in medical texts. Clinical descrip-
tions of mononeuropathies have been known for 
many decades, but tend to be forgotten in academic 
teaching and may need to be rediscovered. One of 
the reasons for their being forgotten is the global 
trend to carry out fewer nerve blockades and to use 
more systemic analgesics.  
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Neuropathic pain can be divided into two dif-
ferent categories. The first is nerve compression or 
nerve trunk pain [1]. This neurogenic pain has been 
attributed to increased activity in, as well as abnor-
mal processing of non-nociceptive input from the 
nervi nervorum [3]. With time, there may be a pro-
gressive loss of small and myelinated nerve fibres [4]. 
It is unclear how important local inflammation is in 
this process. Nerves subjected to stress, either from 
toxicity or pressure, will respond with distal oedema 
[5–7]. Distal oedema may cause entrapment of the 
nerve in an anatomically narrow space. In this model 
the stressor may act proximally, but the pain will be 
experienced distally in a typical place. Another situ-
ation will occur when a nerve is compressed directly 
in the narrow space, for example by nerve traction. 
Here local inflammation may play an important role. 
The other type of neuropathic pain is dysesthetic 
[1]. Here there is no inflammation in the damaged 
nerve, but it depends on the axonal damage, ectopic 
axonal sensitivity and central sensitization. 
In the first type of neuropathic pain there will be 
skin hyperalgesia, while in the second hyperalgesia 
may be accompanied by allodynia. Relieving the 
pressure (decompression) on the nerve will result in 
recovery, while no recovery is expected in the case 
of dysesthetic pain. Again, long-standing pressure 
may evolve from reversible nerve trunk pain to ir-
reversible dysesthetic pain. Both syndromes may 
show decreased sensitivity to opioids [8]. This lim-
ited sensitivity to opioids combined with a lack of 
specific treatment for EN frequently results in opioid 
intoxication.
ENs are different from frequent compression, 
usually by a tumour or its treatment, of the brachial 
or lumbar plexus [9]. In plexopathies, a number of 
nerves are involved, at the same time causing a com-
plex but typical clinical picture. In these cases reduc-
tion of tumour volume by radio- or chemotherapy 
offers pain remission for some time. It is diffe-
rent, however, when symptoms develop a couple 
of months after radiotherapy and in the absence of 
tumour recurrence [9]. This pain may be classified 
as post-radiation damage to the nerves and treated 
like other neuropathic pain. 
The symptoms of ENs depend of the kind of 
nerve impinged. Small, superficial, purely sensory 
nerves will present with burning pain in a typical area 
served by this nerve. Mixed nerves may give paresthe-
sias and loss of muscle function, sometimes with 
long-lasting muscle atrophy. Suprascapular nerve 
entrapment may give atrophy of supra- and infrasp-
inatus muscles without any pain. 
ENs, providing they are recognized in time, are 
usually reversible. Patients with a better progno-
sis may undergo a neurosurgical decompression, 
while patients in poor general condition will need 
to rely on pharmacological treatment. The pain 
is only partially sensitive to opioids and higher 
doses of these drugs are usually needed, especially 
when NSAIDs are contraindicated. The injection 
of local anaesthetics and methylprednisolone 
is another option. It is thought that methylpred-
nisolone acts not only as a local anti-inflammatory 
agent, but also acts by suppression of ectopic 
discharge [10]. 
Injection technique
The tender point should be localized by palpation. 
After disinfection, a 22-gauge 50 ml-long needle 
should be inserted carefully, searching for the bone. 
Once the bone is localized with the needle, the nee-
dle should be “walked” 1–2 mm at a time in order to 
find the nerve. This will be obvious when the patient 
winces. Do not attempt to inject drugs into the nerve. 
Retract the needle by 1–2 mm before injecting the 
drugs. Most of the injections can be carried out at the 
bedside. However, in some patients, ultrasound/ra-
diological localization of the bone is necessary prior 
to injection [35, 36].
Decreasing the opioid dose
Some patients with EN are treated with high 
or very high doses of opioids for their pain. Not 
infrequently, symptoms of opioid-induced hyper-
algesia are superimposed on the symptoms of EN. 
The rapid control of pain with an injection of local 
anaesthetics and methylprednisolone can result 
in increased toxicity of opioids. There is a need 
to decrease the opioid dose rapidly, preferably in 
a clinical environment. Decreasing the dose by 1/3 
instantly and the slower decrease of the second 
1/3 of the dose are usually seen as good practice. 
Too rapid a reduction in the dose may precipitate 
abstinence symptoms. 
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